NanoViricides Inc (NNVC)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $31.41M
Last updated: Nov 17, 2026 at 11:05 AM ET
NanoViricides Inc (NNVC) Earnings: Report Dates and Results
In the quarter ended Jun 30, 2026, NanoViricides reported EPS of -$0.10, above the -$0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NNVC's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 24 quarters below that had an estimate, NNVC beat 15, missed 5 and matched 4. The widest gap in the table came in the quarter ended Jun 30, 2023, when EPS landed 79.53% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.10 | -$0.11 | N/A | +9.09% | Beat | N/A | 1 | 0 up, 1 down | Sep 28, 2026 |
| Mar 31, 2026 | -$0.09 | -$0.08 | -$0.08 - -$0.08 | -12.50% | Miss | N/A | 1 | 0 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$0.11 | -$0.08 | -$0.08 - -$0.08 | -37.50% | Miss | N/A | 1 | 0 up, 0 down | Feb 17, 2026 |
| Sep 30, 2025 | -$0.10 | -$0.18 | -$0.18 - -$0.18 | +44.44% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.12 | -$0.20 | N/A | +40.00% | Beat | N/A | N/A | N/A | Sep 3, 2025 |
| Mar 31, 2025 | -$0.14 | -$0.19 | N/A | +26.32% | Beat | N/A | N/A | N/A | May 15, 2025 |
| Dec 31, 2024 | -$0.14 | -$0.18 | N/A | +22.72% | Beat | N/A | N/A | 0 up, 0 down | Feb 14, 2025 |
| Sep 30, 2024 | -$0.23 | -$0.17 | N/A | -34.12% | Miss | N/A | N/A | 0 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$0.19 | -$0.20 | N/A | +5.00% | Beat | N/A | N/A | 0 up, 0 down | Sep 27, 2024 |
| Mar 31, 2024 | -$0.16 | -$0.19 | -$0.19 - -$0.19 | +15.79% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2024 |
| Dec 31, 2023 | -$0.18 | -$0.19 | N/A | +5.26% | Beat | N/A | N/A | N/A | Feb 14, 2024 |
| Sep 30, 2023 | -$0.17 | -$0.17 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Oct 13, 2023 |
| Jun 30, 2023 | -$0.31 | -$0.17 | N/A | -79.53% | Miss | N/A | N/A | 0 up, 0 down | Aug 30, 2023 |
| Mar 31, 2023 | -$0.15 | -$0.17 | -$0.17 - -$0.17 | +11.76% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$0.15 | -$0.16 | -$0.16 - -$0.16 | +6.25% | Beat | N/A | 1 | 0 up, 0 down | Feb 14, 2023 |
| Sep 30, 2022 | -$0.14 | -$0.17 | -$0.17 - -$0.17 | +17.65% | Beat | N/A | 1 | 0 up, 0 down | Oct 13, 2022 |
| Jun 30, 2022 | -$0.15 | -$0.15 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Aug 31, 2022 |
| Mar 31, 2022 | -$0.16 | -$0.22 | -$0.22 - -$0.22 | +27.27% | Beat | N/A | 1 | 0 up, 0 down | May 17, 2022 |
| Dec 31, 2021 | -$0.17 | -$0.22 | -$0.22 - -$0.22 | +22.73% | Beat | N/A | 1 | 0 up, 0 down | Feb 14, 2022 |
| Sep 30, 2021 | -$0.23 | -$0.20 | -$0.20 - -$0.20 | -15.00% | Miss | N/A | 1 | N/A | Oct 12, 2021 |
| Jun 30, 2021 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 1, 2021 |
| Mar 31, 2021 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2021 |
| Dec 31, 2020 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 16, 2021 |
| Sep 30, 2020 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 13, 2020 |
| Jun 30, 2020 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 2, 2020 |
| Mar 31, 2020 | -$1.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 22, 2020 |
| Dec 31, 2019 | -$0.50 | -$0.60 | N/A | +16.67% | Beat | N/A | N/A | N/A | Feb 14, 2020 |
| Sep 30, 2019 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2019 |
| Jun 30, 2019 | -$0.60 | -$0.80 | N/A | +25.00% | Beat | N/A | N/A | N/A | Aug 23, 2019 |
| Mar 31, 2019 | -$0.60 | -$0.60 | N/A | 0.00% | In line | N/A | N/A | N/A | May 15, 2019 |
| Dec 31, 2018 | -$0.60 | -$0.60 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 19, 2019 |
| Sep 30, 2018 | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 12, 2018 |
| Jun 30, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 29, 2018 |
| Mar 31, 2018 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 21, 2018 |
| Dec 31, 2017 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 21, 2018 |
| Sep 30, 2017 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2017 |
| Jun 30, 2017 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2017 |
| Mar 31, 2017 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2017 |
| Dec 31, 2016 | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2017 |
| Sep 30, 2016 | -$1.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2016 |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$0.40, after -$0.63 the year before. It was -$1.67 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$0.40 | N/A |
| Jun 30, 2025 | -$0.63 | N/A |
| Jun 30, 2024 | -$0.70 | N/A |
| Jun 30, 2023 | -$0.75 | N/A |
| Jun 30, 2022 | -$0.71 | N/A |
| Jun 30, 2021 | -$0.81 | N/A |
| Jun 30, 2020 | -$2.38 | N/A |
| Jun 30, 2019 | -$2.40 | N/A |
| Jun 30, 2018 | -$0.12 | N/A |
| Jun 30, 2017 | -$1.67 | N/A |
Frequently Asked Questions About NNVC
Did NNVC beat earnings estimates last quarter?
Yes. NanoViricides reported EPS of -$0.10 for the quarter ended Jun 30, 2026, above the -$0.11 estimate, a 9.09% surprise.
What EPS do analysts expect from NNVC next quarter?
The consensus EPS estimate for NanoViricides for the quarter ending Dec 31, 2026 is -$0.08 from 1 analyst, with estimates from -$0.08 to -$0.08.
How often does NNVC beat earnings estimates?
NanoViricides beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +7.31%.
NNVC pages: Overview, Earnings, Forecast, Financials, Competitors